AVXL

AVXL Change in Working Capital

$79.00KTTM · USD

Period ending:

AVXL FY Change in Working CapitalUSD
AVXL FY Change in Working Capital2004-09-30: $2.51K2005-09-30: $14.55K2006-09-30: -$9.27K2007-09-30: $454.74K2008-09-30: $460.36K2009-09-30: -$181.002010-09-30: $450.94K2011-09-30: $1.18M2012-09-30: $2.29M2013-09-30: $465.91K2014-09-30: -$336.25K2015-09-30: $1.24M2016-09-30: $640.07K2017-09-30: $382.81K2018-09-30: -$846.67K2019-09-30: $1.30M2020-09-30: $116.52K2021-09-30: -$706.00K2022-09-30: $5.36M2023-09-30: $2.51M2024-09-30: $2.75M2025-09-30: -$4.22M$5.36M-$4.22M
2004-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVXL change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 22 observations from Sep 30, 2004 to Sep 30, 2025.

Anavex Life Sciences Corp Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-4,216,000
2,752,000
2,505,000
5,361,000
-706,000
116,518
1,301,614
-846,674
382,808
640,068
1,237,688
-336,252
465,911
2,291,491
1,179,943
450,936
-181
460,360
454,743
-9,271
14,553
2,505

Compare change in working capital

All AVXL financial metrics · AVXL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.